Search

everythinglearnresearchcommunity

for

Search:↓

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

New understanding and treatments for hair loss are improving, but more research is needed.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Clonally expanded CD8+ T cells cause alopecia areata.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

The combination of the excimer lamp and liquor carbonis detergens is more effective for scalp psoriasis than the lamp alone.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Bimatoprost may help treat hair loss from alopecia areata.

Certain NK cell changes in blood may indicate alopecia areata progression.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Combining antihistamines with topical treatment improves hair regrowth in alopecia areata.